The United States Food and Drug Administration issued a final order approving bemotrizinol as a permitted active ingredient for over-the-counter sunscreens. This regulatory milestone marks the first time the agency has expanded its permitted sunscreen active ingredient list since the late 1990s.
The decision introduces a modern, broad-spectrum chemical ultraviolet filter to the domestic personal care market, altering the product formulation landscape for major consumer packaged goods brands and contract manufacturers.
The approval follows a formal over-the-counter monograph order request submitted by chemical manufacturer DSM Nutritional Products LLC, a subsidiary of dsm-firmenich, which will market the ingredient under the trade name Parsol Shield. Under the parameters of the regulatory filing, bemotrizinol is authorized for use in domestic sunscreen formulations at concentrations up to 6%.
According to federal documentation, the substance met stringent safety standards for ultraviolet radiation protection while demonstrating exceptionally low levels of dermal absorption into the human body. The regulatory agency classified bemotrizinol as generally recognized as safe and effective for adults and children aged six months and older.
The regulatory clearance was accelerated by modern administrative pathways designed to reduce chronic gridlock in federal product approvals. Bemotrizinol represents the first over-the-counter active ingredient approved via the streamlined monograph reform framework established by the Coronavirus Aid, Relief, and Economic Security Act passed by Congress in 2020. Prior to this structural optimization, updates to the federal nonprescription drug database faced multi-decade administrative delays.
The final order materialized just seven months after the initial proposed order was published in December 2025, signaling a permanent operational shift in how federal health agencies process chemical innovation and market safety reviews.
The inclusion of bemotrizinol directly addresses long-standing technical constraints within the personal care product supply chain. Unlike existing chemical UV filters approved in the United States, which typically isolate protection to either UVA or UVB wavelengths, bemotrizinol provides simultaneous broad-spectrum coverage against both burning and deeper cellular degradation.
Furthermore, the chemical structure exhibits high photostability, meaning it does not break down rapidly when exposed to direct sunlight. This property allows research and development teams to reduce their reliance on complex stabilizer blends, simplifying chemical sourcing requirements and streamlining raw material inventories.
From a product development perspective, the physical properties of the ingredient grant formulators significantly greater flexibility. Bemotrizinol possesses high solubility in standard cosmetic emollients, allowing manufacturers to engineer lightweight, water-resistant creams and lotions that avoid the chalky white residue characteristic of mineral-based alternatives like zinc oxide and titanium dioxide. Industry research indicates that cosmetic elegance and skin-feel are primary drivers of repeat consumer purchasing behavior.
Consequently, major enterprise brands, including Neutrogena parent company Kenvue, have announced plans to integrate the new filter into their long-term product pipeline to capture shifting consumer demand.
The commercialization framework includes strategic market protections for the initial applicant. The regulatory structure grants DSM Nutritional Products an 18-month exclusivity period for the sale and distribution of bemotrizinol within the domestic market before the chemical becomes universally accessible to competing ingredient suppliers.
This exclusivity window will compress initial product launches, as brands negotiate supply contracts to secure early-market advantages. Industry analysts anticipate that the introduction of globally scalable solutions will trigger widespread formula updates across the prestige and mass-market skincare sectors, testing retail logistics channels as manufacturers scale production ahead of seasonal retail distribution cycles.
